Endogeneity issue – 2SLS model and propensity score matching
| (1) First stage | (2) Second stage | (3) PSM | |
|---|---|---|---|
| Variables | Nature_Dep | WACC | WACC |
| Nature_Dep | 0.047*** | 0.002*** | |
| (3.598) | (2.671) | ||
| Nature_Dep_iv | 0.185*** | ||
| (4.975) | |||
| Size | 0.016*** | −0.001*** | −0.000 |
| (7.239) | (−4.000) | (−1.025) | |
| ROA | 0.011 | −0.016*** | −0.014*** |
| (0.402) | (−6.013) | (−4.491) | |
| Lev | −0.052** | −0.036*** | −0.039*** |
| (−2.463) | (−19.852) | (−19.816) | |
| Capex | 0.252*** | 0.020*** | 0.021*** |
| (3.444) | (2.965) | (2.621) | |
| Salesgrowth | −0.016*** | 0.004*** | 0.003*** |
| (−3.916) | (7.510) | (5.848) | |
| Tangibility | 0.259*** | −0.020*** | −0.007*** |
| (11.635) | (−5.360) | (−3.699) | |
| Tobinsq | 0.002 | 0.001*** | 0.001*** |
| (1.433) | (3.857) | (4.327) | |
| GDP | −0.046* | −0.047*** | −0.037*** |
| (−1.932) | (−15.894) | (−6.948) | |
| Constant | 2.536*** | 0.468*** | 0.454*** |
| (8.427) | (8.944) | (8.519) | |
| Observations | 56,123 | 56,123 | 45,120 |
| R-squared | 0.253 | 0.138 | 0.393 |
| Industry FE | Yes | Yes | Yes |
| Country FE | Yes | Yes | Yes |
| Year FE | Yes | Yes | Yes |
| First stage F-statistic of excluded instrument | 24.75*** | ||
| Anderson-Rubin 95% confidence interval | [0.0214, 0.0728] | ||
| Kleibergen-Paap rk Lagrange Multiplier (LM) statistics | 26.905*** |
| (1) First stage | (2) Second stage | (3) PSM | |
|---|---|---|---|
| Variables | Nature_Dep | WACC | WACC |
| 0.047*** | 0.002*** | ||
| (3.598) | (2.671) | ||
| 0.185*** | |||
| (4.975) | |||
| 0.016*** | −0.001*** | −0.000 | |
| (7.239) | (−4.000) | (−1.025) | |
| 0.011 | −0.016*** | −0.014*** | |
| (0.402) | (−6.013) | (−4.491) | |
| −0.052** | −0.036*** | −0.039*** | |
| (−2.463) | (−19.852) | (−19.816) | |
| 0.252*** | 0.020*** | 0.021*** | |
| (3.444) | (2.965) | (2.621) | |
| −0.016*** | 0.004*** | 0.003*** | |
| (−3.916) | (7.510) | (5.848) | |
| 0.259*** | −0.020*** | −0.007*** | |
| (11.635) | (−5.360) | (−3.699) | |
| 0.002 | 0.001*** | 0.001*** | |
| (1.433) | (3.857) | (4.327) | |
| −0.046* | −0.047*** | −0.037*** | |
| (−1.932) | (−15.894) | (−6.948) | |
| 2.536*** | 0.468*** | 0.454*** | |
| (8.427) | (8.944) | (8.519) | |
| Observations | 56,123 | 56,123 | 45,120 |
| 0.253 | 0.138 | 0.393 | |
| Industry FE | Yes | Yes | Yes |
| Country FE | Yes | Yes | Yes |
| Year FE | Yes | Yes | Yes |
| First stage F-statistic of excluded instrument | 24.75*** | ||
| Anderson-Rubin 95% confidence interval | [0.0214, 0.0728] | ||
| Kleibergen-Paap rk Lagrange Multiplier (LM) statistics | 26.905*** |
Note(s): This table reports the fixed-effects regression results addressing potential endogeneity concerns using a two-stage least squares (2SLS) approach and propensity score matching (PSM). In columns (1) and (2), the dependent variable in the first stage is Nature_Dep, while WACC is used in the second-stage regression. The instrument variable (Nature_Dep_iv) is the average nature dependence of industry peers in the same country and year, excluding the focal firm. Column (3) reports the results based on a matched sample obtained from the PSM approach. Industry, country, and time fixed-effects are considered in all regressions. Heteroscedasticity-robust standard errors are clustered at the firm level in parentheses. *, **, *** indicate the significance levels at 10%, 5% and 1%, respectively
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.